Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study - PubMed (original) (raw)

Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study

Sarah R Preis et al. Obesity (Silver Spring). 2010 Nov.

Abstract

Insulin resistance is associated with central obesity and an increased risk of cardiovascular disease. Our objective is to examine the association between abdominal subcutaneous (SAT) and visceral adipose tissue (VAT) and insulin resistance, to determine which fat depot is a stronger correlate of insulin resistance, and to assess whether there was an interaction between SAT, VAT, and age, sex, or BMI. Participants without diabetes from the Framingham Heart Study (FHS), who underwent multidetector computed tomography to assess SAT and VAT (n = 3,093; 48% women; mean age 50.4 years; mean BMI 27.6 kg/m(2)), were evaluated. Insulin resistance was measured using the homeostasis model and defined as HOMA(IR) ≥75th percentile. Logistic regression models, adjusted for age, sex, smoking, alcohol, menopausal status, and hormone replacement therapy use, were used to assess the association between fat measures and insulin resistance. The odds ratio (OR) for insulin resistance per standard deviation increase in SAT was 2.5 (95% confidence interval (CI): 2.2-2.7; P < 0.0001), whereas the OR for insulin resistance per standard deviation increase in VAT was 3.5 (95% CI: 3.1-3.9; P < 0.0001). Overall, VAT was a stronger correlate of insulin resistance than SAT (P < 0.0001 for SAT vs. VAT comparison). After adjustment for BMI, the OR of insulin resistance for VAT was 2.2 (95% CI: 1.9-2.5; P < 0.0001). We observed an interaction between VAT and BMI for insulin (P interaction = 0.0004), proinsulin (P interaction = 0.003), and HOMA(IR) (P interaction = 0.003), where VAT had a stronger association in obese individuals. In conclusion, SAT and VAT are both correlates of insulin resistance; however, VAT is a stronger correlate of insulin resistance than SAT.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Multivariable-adjusted mean insulin variables by tertiles of abdominal subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT). HOMAIR, homeostasis model assessment of insulin resistance. Note: Bars represent 95% confidence intervals. *Adjusted for age, sex, current smoking, regular alcohol consumption, menopausal status, and hormone replacement therapy use. †Median values of SAT: tertile 1 (men, 1,597 cm3; women, 1,722 cm3); tertile 2 (men, 2,401 cm3; women, 2,861 cm3); tertile 3 (men, 3,600 cm3; women, 4,656 cm3). ‡P interaction refers to the interaction between SAT and VAT. §Median values of VAT: tertile 1 (men, 1,234 cm3; women, 543 cm3); tertile 2 (men, 2,092 cm3; women, 1,180 cm3); tertile 3 (men, 3,127 cm3; women, 2,104 cm3).

Similar articles

Cited by

References

    1. Bonora E, Kiechl S, Willeit J, et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study. Diabetes Care. 2007;30:318–324. - PubMed
    1. Fujimoto WY. The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus. Am J Med. 2000;108(Suppl 6a):9S–14S. - PubMed
    1. Jeppesen J, Hansen TW, Rasmussen S, et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol. 2007;49:2112–2119. - PubMed
    1. McLaughlin T, Allison G, Abbasi F, Lamendola C, Reaven G. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metab Clin Exp. 2004;53:495–499. - PubMed
    1. Després JP, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28:1039–1049. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources